1Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome,and associated costs of care. Crit Care Meal,2001, 29(7) :1303-1310.
2Martin GS, Mannino DM, Eaton S, et al. The Epidemiology of Sepsis in the United States from 1979 through 2000. N Engl J Med,2003,348 ( 16 ) : 1546-1554.
3Dombrovskiv VY, Martin AA, Sunderram J, et al. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States : a trend analysis from 1993 to 2003. Crit Care Med,2007,35(5) : 1244-1250.
4Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of critical care Medicine. Chest, 1992,101(6) : 1644-1655.
5Opal SM, Esmon CT. Bench-to-bedside review: functional relationships between coagulation and the innate immune re- sponse and their respective roles in the pathogenesis of sepsis. Crit Care,2003,7( 1 ) : 23-38.
6Irequi M, Ward S, Sherman G, et al. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest, 2002,122 ( 1 ) : 262- 268.
7Rivers E, Nguyen B, Havstad S, et al. Early goal - directed therapy in the treatment of severe sepsis and septic shock. N End J Med ,2001,345 ( 19 ) : 1368-1377.
8Finfer S, Bellomo R, Bovee N, et al. A Comparison of Albumin and saline for fluid resuscitation in the intensive eare unit. N Engl J Med,2004,350(22) : 2247-2256.
9Dellinger RP. Cardiovascular management of septic shock. Crit Care Med,2003,31(3) :946-955.
10De Backer D, Creteur J,Silva E, et al. Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best? Crit Care Med,2003,31: 1659 - 1667.
二级参考文献11
1Dellinger P, Carlet JM, Masur H, et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med, 2004, 30: 536-555.
2Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med, 2001, 345: 1368-1377.
3Iregui M, Ward S, Sherman G, et al. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest, 2002, 122: 262-268.
4The SAFE Study Investigators. A Comparison of Albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med, 2004, 350:2247-2256.
5De Backer D, Creteur J, Silva E, et al. Effects of dopamine,norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best? Crit Care Med, 2003, 31:1659-1667.
6Kellum J, Decker J. Use of dopamine in acute renal failure: a metaanalysis. Crit Care Med, 2003, 31: 1526-1531.
7Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA, 2002, 288:862-871.
8Van Den Berghe G, Wouters PJ, Bouillon R, et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control Crit Care Med, 2003, 31: 359-366.
9Bernard GR, Vincent JL, Laterre PF, et al. Recombinant human protein C worldwide evaluation in severe sepsis (PROWESS) study group. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med, 2001,344: 699-709.
10Cole L, Bellomo R, Joumois D, et al. High-volume haemofiltration in human septic shock. Intensive Care Med, 2001, 27:978-986.
9ANGUSDC,LINDE-ZWIRBLE W T,LIDICKER J,et al.Epidemiology of severe sepisis in the United States:Analysis of incidence,outcome,and asociatedncosts of care[J].Crit care MED,2001,29: 1303-1310.
10OPAL S M,ESMON C T.Bench to-bedside review:functional reIationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsis[J].Crit Care,2003,7 (1):23-38.
